United States · FDA National Drug Code directory
Lumryz
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13551-004_bd9a6c48-be50-44e5-8cbb-87cbaafe936d
- Product NDC
- 13551-004
- Form
- FOR SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- sodium oxybate
- Labeler
- Avadel CNS Pharmaceuticals, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230501
- Source listing expiry
- 20261231
Source-listed ingredients
- SODIUM OXYBATE — 9 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 PACKET in 1 CARTON (13551-004-07) / 1 FOR SUSPENSION, EXTENDED RELEASE in 1 PACKET · 13551-004-07
- 30 PACKET in 1 CARTON (13551-004-30) / 1 FOR SUSPENSION, EXTENDED RELEASE in 1 PACKET · 13551-004-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →